Stocklytics Platform
Asset logo for symbol MRVI
Maravai LifeSciences Holdings
MRVI45
$8.87arrow_drop_down1.98%-$0.18
Asset logo for symbol MRVI
MRVI45

$8.87

arrow_drop_down1.98%
Key Stats
Open$9.01
Prev. Close$9.05
EPS-1.00
DividendNon-Dividend
Next Earnings Date-
Dividend Yield %-
PE Ratio-
LOWHIGH
Day Range8.85
9.28
52 Week Range4.52
11.55
Ratios
EPS-1.00
Fundamentals
Payout Ratio-
Industry average yield2.94%
Last Dividend pay date-
Dividend per share-
Dividend yield forecast-

Stock Analysis

Technicals

Summarizing what the indicators are suggesting.

Strong Buy
Buy
Neutral
Sell
Strong Sell

Analyst rating

An aggregate view of professional's ratings.

Strong Buy
Buy
Neutral
Sell
Strong Sell

Stock Performance

MRVI-
US Healthcare Sector-
US Market-
check_circle

MRVI / Market

MRVI exceeded the US Market which returned -1.02% over the last twenty four hours.
check_circle

MRVI / Healthcare Sector

MRVI exceeded the US Healthcare sector which returned -0.54% over the last twenty four hours.

Maravai LifeSciences Holdings (MRVI) Statistics

Maravai LifeSciences Holdings Inc (MRVI) is a leading provider of life sciences research tools and services. As of the latest valuation metrics, MRVI has shown impressive growth and financial performance. The company's valuation metrics indicate its potential for future success and investor confidence. With strong fundamentals and a solid track record, MRVI is a promising investment in the life sciences sector.
When it comes to stock performance, MRVI has consistently outperformed its sector. The company's stock statistics demonstrate its ability to deliver shareholder value and generate solid returns. Investors can rely on MRVI's strong performance to achieve their financial goals.
add Maravai LifeSciences Holdings  to watchlist

Keep an eye on Maravai LifeSciences Holdings

Adding the right stocks to your watchlist can provide valuable insights and opportunities for strategic decision-making.

Frequently Asked Questions

search
help

How has Maravai LifeSciences Holdings (MRVI) stock's performance compared to its sector and the market over the past year?

Over the past year, Maravai LifeSciences Holdings (MRVI) has experienced a price change of . Compared to the Healthcare sector, which saw a change of 25.88%, Maravai LifeSciences Holdings has underperformed compared to its sector, indicating its relative standing within the Healthcare sector. Against the broader market's change of 61.39%, it has fallen short of the market average. This comparison highlights Maravai LifeSciences Holdings 's performance relative to both its sector and the overall market over the last year.
help

What is the PE ratio of Maravai LifeSciences Holdings (MRVI) stock?

The PE ratio for Maravai LifeSciences Holdings (MRVI) is currently not available. This could be due to a variety of factors such as the company not having positive earnings at the moment or recent updates not being reflected.
help

What is the EPS of Maravai LifeSciences Holdings (MRVI) stock?

The Earnings Per Share (EPS) for Maravai LifeSciences Holdings (MRVI), calculated on a diluted basis, is -$1. EPS is a key indicator of a company's profitability, showing the portion of a company's profit allocated to each outstanding share of common stock.
help

What is the operating margin of Maravai LifeSciences Holdings (MRVI) stock?

The operating margin for Maravai LifeSciences Holdings (MRVI) is -14.59%. This metric represents the percentage of revenue that remains after paying for variable production costs, indicating the efficiency and profitability of the company's core business operations.
help

What is the EBITDA of Maravai LifeSciences Holdings (MRVI) stock?

The EBITDA (Earnings Before Interest, Taxes, Depreciation, and Amortization) of Maravai LifeSciences Holdings (MRVI) is $704.6M. EBITDA is a widely used earnings metric to assess a company's operational efficiency and profitability before the impact of non-operating decisions such as financing, accounting, and tax environments.
help

How much debt does Maravai LifeSciences Holdings (MRVI) have?

Maravai LifeSciences Holdings (MRVI) has a total debt of $615.2M. The net debt, which accounts for cash and cash equivalents against the total debt, is -$11.29M.

Sign up for our newsletter

Join our exclusive community of over one million investment enthusiasts and receive our free newsletter filled with analysis, news, and updates every weekday.

Take Your Investments to a Whole New Level

Stocklytics Platform

© 2024 Stocklytics.com All rights reserved.

Stocklytics.com is not a financial advisor, and all data and information provided on this website are for informational purposes only. The content on Stocklytics.com is not intended to be a substitute for professional financial advice. Investors should conduct their own research and consult with a qualified financial advisor before making any investment decisions. Stocklytics.com makes no representations or warranties regarding the accuracy, completeness, or suitability of any information provided and is not liable for any errors or omissions, or for any losses incurred as a result of reliance on the information provided on this website.

Stocklytics Discord public channelStocklytics X Social Media